254 related articles for article (PubMed ID: 30670922)
1. Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?
Scaglione F; Petrini O
Clin Med Insights Ear Nose Throat; 2019; 12():1179550618821930. PubMed ID: 30670922
[TBL] [Abstract][Full Text] [Related]
2. Safety and usage pattern of an over-the-counter ambroxol cough syrup: a community pharmacy-based cohort study.
Schulz M; Hämmerlein A; Hinkel U; Weis G; Gillissen A
Int J Clin Pharmacol Ther; 2006 Sep; 44(9):409-21. PubMed ID: 16995329
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro analysis of inhibition of rhinovirus and influenza virus replication by mucoactive secretolytic agents and plant extracts.
Walther C; Döring K; Schmidtke M
BMC Complement Med Ther; 2020 Dec; 20(1):380. PubMed ID: 33357221
[TBL] [Abstract][Full Text] [Related]
4. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
5. [Acute bronchitis - modern possibilities of mucactive therapy].
Zaitsev AA; Filon EA; Storozheva YI
Ter Arkh; 2023 Dec; 95(11):943-950. PubMed ID: 38158950
[TBL] [Abstract][Full Text] [Related]
6. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.
Chalumeau M; Duijvestijn YC
Cochrane Database Syst Rev; 2013 May; (5):CD003124. PubMed ID: 23728642
[TBL] [Abstract][Full Text] [Related]
7. Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections.
Albrecht HH; Dicpinigaitis PV; Guenin EP
Multidiscip Respir Med; 2017; 12():31. PubMed ID: 29238574
[TBL] [Abstract][Full Text] [Related]
8. A reappraisal of the mucoactive activity and clinical efficacy of bromhexine.
Zanasi A; Mazzolini M; Kantar A
Multidiscip Respir Med; 2017; 12():7. PubMed ID: 28331610
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis].
Zaitsev AA; Leshchenko IV; Esaulova NA; Viktorova IA
Ter Arkh; 2023 Apr; 95(3):236-242. PubMed ID: 37167145
[TBL] [Abstract][Full Text] [Related]
10. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.
Duijvestijn YC; Mourdi N; Smucny J; Pons G; Chalumeau M
Cochrane Database Syst Rev; 2009 Jan; (1):CD003124. PubMed ID: 19160217
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
12. Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults.
Chang CC; Cheng AC; Chang AB
Cochrane Database Syst Rev; 2012 Feb; (2):CD006088. PubMed ID: 22336815
[TBL] [Abstract][Full Text] [Related]
13. Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases.
Dal Negro R; Pozzi E; Cella SG
Pulm Pharmacol Ther; 2018 Dec; 53():80-85. PubMed ID: 30352285
[TBL] [Abstract][Full Text] [Related]
14. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
[TBL] [Abstract][Full Text] [Related]
15. Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults.
Chang CC; Cheng AC; Chang AB
Cochrane Database Syst Rev; 2007 Oct; (4):CD006088. PubMed ID: 17943884
[TBL] [Abstract][Full Text] [Related]
16. Mucoactive drugs.
Balsamo R; Lanata L; Egan CG
Eur Respir Rev; 2010 Jun; 19(116):127-33. PubMed ID: 20956181
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of acute bronchitis treatment in adults--a comparison of Bronchosol® syrup and synthetic preparations with ambroxol. Results of observational study].
Fal AM; Schönknecht K
Wiad Lek; 2015; 68(2):139-44. PubMed ID: 26181148
[TBL] [Abstract][Full Text] [Related]
18. Observational prospective study comparing mucoactive and antibiotic treament in the management of acute cough from upper respiratory tract infections.
Zanasi A; Lecchi M; Mazzolini M; Mastroroberto M; Nardi E; Morselli-Labate A
Minerva Med; 2015 Oct; 106(5):239-246. PubMed ID: 26495821
[TBL] [Abstract][Full Text] [Related]
19. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol.
Fadda G
Minerva Med; 2001 Aug; 92(4):269-75. PubMed ID: 11535970
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the efficacy of mucoactive aerosol therapy.
Fuloria M; Rubin BK
Respir Care; 2000 Jul; 45(7):868-73. PubMed ID: 10926385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
